BullFrog AI Holdings (BFRGW) Net Equity Issued and Repurchased (2023 - 2025)
BullFrog AI Holdings' (BFRGW) quarterly Net Equity Issued and Repurchased came in at $1.5 million in Q4 2025, up 124.78% quarter-over-quarter from $678934.0 in Q3 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (changed N/A YoY), and the FY2025 full-year result was $2.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $1.5 million in Q4 2025 per BFRGW's latest filing, from $678934.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $7.3 million in Q1 2023 and bottomed at $678934.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.86 Bn | 196.87 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.23 Bn | 178.05 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.14 Bn | 124.29 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.88 Bn | 74.88 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Argenx Se | 61.72 Bn | 56.54 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.82 Bn | 49.68 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.79 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.28 Bn | 29.99 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.40 Bn | 30.40 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 678,934.00 |
| Mar 31, 2023 | 7.29 Mn |